Anxiety in Black Men With Prostate Cancer: Validation of the Memorial Anxiety Scale for Prostate Cancer in an Sample of Black Men

This study is being done to see if a standard tool used to check anxiety in white men works well for Black men. The tool is used only for men who have prostate cancer. It is meant to see how the cancer affects men. If the investigators have a good tool, it is more likely that the investigators can help those who have high levels of anxiety. This test is known as the Memorial Anxiety Scale for Prostate Cancer (also called the MAX-PC).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Prostate Cancer Anxiety Disorders Genital Diseases Genital Diseases, Male Genital Neoplasms, Male Male Urogenital Diseases Mental Disorders Neoplasms Neoplasms by Site Prostatic Diseases Prostatic Neoplasms Urogenital Diseases Urogenital Neoplasms

Age range

18 year and older

Sex eligibility

Male

Study type

Observational

Primary location

Downstate Medical Center, Brooklyn, New York, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

18 years of age or older
Patients who are being monitored by PSA tests, who will have a PSA test done on the day of their current clinic visit or prior to their clinic visit, but prior to being informed of the results
Diagnosis of prostate cancer
Ethnicity: Black, African-American, or of African descent (and will include those men who identify as Black and Hispanic).
Ability to comprehend and complete questionnaires in English

Exclusion criteria

Major psychopathology or cognitive impairment likely, in the judgment of the research staff, to interfere with the participation or completion of the protocol
Other non-Black or non-African-American ethnic groups

Treatment and study plan

questionnaires of quality of life

Behavioral

Subjects will be asked to complete the MAX-PC along with additional psychosocial questionnaires which include anxiety, depression coping methods, resilience spirituality, religiosity, and quality of life measures and will take approximately one 30 to 45 minutes to complete by patient.

Primary outcomes

To establish the psychometric properties of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC) in Black men with prostate cancer.

Time frame: within one to three weeks of receiving their PSA scores from their physician

Secondary outcomes

To explore the prevalence of distress, anxiety, and depression in Black men with prostate cancer.

Time frame: within one to three weeks of receiving their PSA scores from their physician

Sponsors and collaborators

Lead sponsor

Memorial Sloan Kettering Cancer Center

Other

Collaborators

Kings County Hospital Center
State University of New York - Downstate Medical Center
University School of Medicine(VA-NYU)

Registry information

Important dates

Study start: 2010
Primary completion: 2022
Study completion: 2022
First posted: Dec 28, 2007
Registry last updated: May 4, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed